MedTrace Logo

the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.

NCT05942547 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2023-07-12

No results posted yet for this study

Summary

This is a randomized, controlled study evaluating diosmin tablets administered daily for 3 months. The purpose of the study is to evaluate the efficacy and safety of diosmin on non-diabetic patients with non-alcoholic steatohepatitis.

Conditions

  • Non Alcoholic Steatohepatitis

Interventions

DRUG

Diosmin

diosmin 600mg twice daily

DRUG

Placebo

twice daily

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • tarek mohamed mostafa, professor · Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-10
Primary Completion
2023-10-10
Completion
2025-06-10

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05942547 on ClinicalTrials.gov